NCT00364221View on ClinicalTrials.gov

Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

October 31, 2006

Conditions
Metabolic SyndromeInsulin Resistance
Interventions
DRUG

Rosiglitazone

Trial Locations (1)

80262

University of Colorado at Denver and Health Sciences Center General Clinical Research Center, Denver

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT00364221 - Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome | Biotech Hunter | Biotech Hunter